id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
1182937,10ff6c19-ef99-42e4-898d-1cef736c096e,Q4,VENABLE LLP,39941,ENDO PHARMACEUTICALS INC,2011,fourth_quarter,TAX,Life Sciences Jobs and Investment Act (S. 1410; H.R. 2632).,"HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2012-01-10T10:09:57-05:00
1182938,10ff6c19-ef99-42e4-898d-1cef736c096e,Q4,VENABLE LLP,39941,ENDO PHARMACEUTICALS INC,2011,fourth_quarter,HCR,The Life Sciences Jobs and Investment Act of 2011.  (S. 1410; H.R. 2632),"HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2012-01-10T10:09:57-05:00
1182939,10ff6c19-ef99-42e4-898d-1cef736c096e,Q4,VENABLE LLP,39941,ENDO PHARMACEUTICALS INC,2011,fourth_quarter,PHA,"General issues affecting the pharmaceutical industry and bioequivelence.
The Life Sciences Investment Act (S. 1410; H.R. 2632)","HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2012-01-10T10:09:57-05:00